Chimerix to Report Third Quarter 2022 Financial Results and Provide an Operational Update on November 3, 2022
October 27 2022 - 4:30PM
Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose
mission is to develop medicines that meaningfully improve and
extend lives of patients facing deadly diseases, today announced
that it will host a live conference call and audio webcast on
Thursday, November 3, 2022 at 8:30 a.m. ET to report financial
results for the third quarter ended September 30, 2022, and to
provide a business overview.
To access the live conference call, please dial (646) 307-1963
(domestic) or (800) 715-9871 (international) at least five minutes
prior to the start time, and refer to conference ID 2765632. A live
audio webcast of the call will also be available on the Investors’
section of the Company's website, www.chimerix.com. An archived
webcast will be available on the Chimerix website approximately two
hours after the event.
About Chimerix
Chimerix is a biopharmaceutical company with a mission to
develop medicines that meaningfully improve and extend the lives of
patients facing deadly diseases. The Company’s most advanced
clinical-stage development program, ONC201, is in development for
H3 K27M-mutant glioma.
CONTACTS: Michelle
LaSpaluto919 972-7115ir@chimerix.comWill O’ConnorStern Investor
Relations212-362-1200will@sternir.com
Chimerix (NASDAQ:CMRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Chimerix (NASDAQ:CMRX)
Historical Stock Chart
From Jul 2023 to Jul 2024